SLC11A1 and central nervous system cancer: The TCGA cohort was treated as a validation set, and the results were highly consistent with the above results, which revealed that the SLC11A1 expression was associated with immune infiltration and microenvironment remodeling within gliomas (Figure 5E and Supplementary Figure 3C).